Beck, T.C.; Springs, K.; Morningstar, J.E.; Mills, C.; Stoddard, A.; Guo, L.; Moore, K.; Gensemer, C.; Biggs, R.; Petrucci, T.;
et al. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules 2022, 27, 3678.
https://doi.org/10.3390/molecules27123678
AMA Style
Beck TC, Springs K, Morningstar JE, Mills C, Stoddard A, Guo L, Moore K, Gensemer C, Biggs R, Petrucci T,
et al. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules. 2022; 27(12):3678.
https://doi.org/10.3390/molecules27123678
Chicago/Turabian Style
Beck, Tyler C., Kendra Springs, Jordan E. Morningstar, Catherine Mills, Andrew Stoddard, Lilong Guo, Kelsey Moore, Cortney Gensemer, Rachel Biggs, Taylor Petrucci,
and et al. 2022. "Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs" Molecules 27, no. 12: 3678.
https://doi.org/10.3390/molecules27123678
APA Style
Beck, T. C., Springs, K., Morningstar, J. E., Mills, C., Stoddard, A., Guo, L., Moore, K., Gensemer, C., Biggs, R., Petrucci, T., Kwon, J., Stayer, K., Koren, N., Dunne, J., Fulmer, D., Vohra, A., Mai, L., Dooley, S., Weninger, J.,
... Norris, R. A.
(2022). Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules, 27(12), 3678.
https://doi.org/10.3390/molecules27123678
